Oncology

Ovarian Cancer is one of the commonly diagnosed cancer among women worldwide. It accounts for nearly 239,000 new cases and 152,000 deaths per year, globally. Treatment landscape of Ovarian Cancer has evolved over the years as the available chemotherapies were not that efficient, giving rise to targeted therapies as the major treatment in this field, showing better efficacy and resulting in increased usage over the past decade. PARP is one of the most widely researched targets in this area, and the therapies that inhibit PARP target DNA repair. These therapies have gained popularity because of their high oral bioavailability and convenient dosing schedule. PARP inhibito...